TMS Alteration of the Reward Positivity
Causal Dissociation of Value Contributions to the Reward Positivity
1 other identifier
interventional
9
1 country
1
Brief Summary
The aim of this proposal is to demonstrate that stimulation of different brain regions differently affects the electroencephalographic feature known as the Reward Positivity (RewP).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Aug 2022
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 29, 2022
CompletedFirst Posted
Study publicly available on registry
July 5, 2022
CompletedStudy Start
First participant enrolled
August 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 17, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
October 17, 2024
CompletedResults Posted
Study results publicly available
December 10, 2024
CompletedDecember 10, 2024
December 1, 2024
1.3 years
June 29, 2022
November 6, 2024
December 5, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Reward Positivity
EEG Amplitude 200-400 ms following reward receipt
During intervention
Study Arms (2)
Theta Stim
EXPERIMENTALTo stimulate fMRI-informed individualized targets in dlPFC to diminish affective modulation of the RewP. Based on our working hypothesis, TMS Figure-8 coil stimulation should diminish affective modulation of RewP amplitude when compared to sham.
Sham Stim
SHAM COMPARATORSham stimulation. The Reward Positivity should be unaffected.
Interventions
Eligibility Criteria
You may qualify if:
- Men or women aged 18-30
You may not qualify if:
- Participants unwilling or unable to give informed consent
- Presence of other known medical or psychiatric comorbidity that in the investigator's opinion would compromise participation in the study
- MEG/MRI contraindications
- History of psychosis
- Not fluent in English
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of New Mexico - Logan hall
Albuquerque, New Mexico, 87106, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Results Point of Contact
- Title
- Dr. James F. Cavanagh
- Organization
- University of New Mexico
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
June 29, 2022
First Posted
July 5, 2022
Study Start
August 1, 2022
Primary Completion
November 17, 2023
Study Completion
October 17, 2024
Last Updated
December 10, 2024
Results First Posted
December 10, 2024
Record last verified: 2024-12
Data Sharing
- IPD Sharing
- Will not share